| Literature DB >> 32949778 |
Rafael V Picon1, Ioná Carreno2, André Anjos da Silva3, Márcio Mossmann4, Gabriela Laste5, Guilherme de Campos Domingues4, Lara Faria Fernandes Heringer4, Brenda Rodrigues Gheno4, Leticia Leão Alvarenga4, Magali Conte6.
Abstract
OBJECTIVES: To assess population-based prevalence, risk factors, hospitalization, and infection fatality rates (IFR) associated with COVID-19.Entities:
Keywords: COVID-19; Hospitalization; Infection fatality rate; Prevalence; SARS-CoV-2
Mesh:
Year: 2020 PMID: 32949778 PMCID: PMC7493765 DOI: 10.1016/j.ijid.2020.09.028
Source DB: PubMed Journal: Int J Infect Dis ISSN: 1201-9712 Impact factor: 3.623
Figure 1Daily confirmed COVID-19 cases, active cases per day, and cumulative case counts (A), and daily COVID-19 hospital admissions and cumulative hospital admissions counts (B) from March 15 to June 27, 2020.
Black lines are cumulative confirmed case counts (A) and cumulative hospital admissions (B). Yellow columns are daily confirmed cases. Red line is active cases per day. Green columns are daily hospital admissions. Yellow shading shows periods when meat processing plants A and B (MPP-A and MPP-B, respectively) performed mass screening for anti-SARS-CoV-2 antibodies on employees. Blue shading shows periods of data collection of Survey 1 and 2.
Samples characteristics by survey and SARS-CoV-2 infection status.
| Survey 1 (n = 1450) | Survey 2 (n = 1127) | |||||
|---|---|---|---|---|---|---|
| SARS-CoV-2 | SARS-CoV-2 | |||||
| Positive | Negative | Positive | Negative | |||
| SARS-CoV-2-positive crude case count, No. (%) | 46 (100) | NA | NA | 23 (100) | NA | NA |
| Lateral flow immunoassay | 40 (87.0) | NA | NA | 20 (87.0) | NA | NA |
| RT-PCR | 2 (4.3) | NA | NA | 1 (4.3) | NA | NA |
| Previously documented infection | 4 (8.7) | NA | NA | 2 (8.7) | NA | NA |
| Active COVID-19 cases | 5 (10.9) | NA | NA | 2 (8.7) | NA | NA |
| Crude prevalence of infection | ||||||
| Unadjusted for DEFF, % (95% CI) | 3.17 (2.32–4.23) | NA | NA | 2.04 (1.29–3.06) | NA | NA |
| Adjusted for DEFF, % (95% CI) | 3.17 (2.22–4.52) | NA | NA | 2.04 (1.23–3.35) | NA | NA |
| Corrected prevalence of infection | 4.03 (3.08–5.18) | NA | NA | 2.59 (1.75–3.70) | NA | NA |
| Resident adults per household, mean (SD) | 2.4 (1.0) | 2.2 (0.9) | 0.170 | 2.2 (1.0) | 2.1 (0.9) | 0.610 |
| Resident adults present per household, mean (SD) | 1.8 (0.9) | 1.6 (0.8) | 0.082 | 1.5 (0.8) | 1.7 (0.8) | 0.312 |
| Female, No. (%) | 28 (63.6) | 924 (65.8) | 0.749 | 18 (78.3) | 705 (63.9) | 0.190 |
| Age, median (IQR) | 49.9 (31.1) | 49.9 (26.9) | 0.376 | 45.4 (24.8) | 49.6 (27.8) | 0.365 |
| White skin, No. (%) | 32 (69.6) | 1150 (81.9) | <0.0001 | 12 (52.2%) | 911 (82.5) | <0.0001 |
| Monthly household income | 1285 (1172) | 1999 (2217) | 0.046 | 1491 (359) | 1949 (1916) | 0.301 |
| Schooling years, median (IQR) | 8 (6) | 11 (8) | 0.002 | 8 (10) | 11 (8) | 0.329 |
| Meat-processing plant worker, No. (%) | 8 (18.2) | 53 (3.8) | <0.0001 | 7 (30.4) | 33 (3.0) | <0.0001 |
| BCG vaccinated, No. (%) | 34 (77.3) | 1193 (85.0) | 0.197 | 19 (90.5) | 940 (85.1) | 0.756 |
| Social distancing recommendations, median (IQR) | ||||||
| Global adherence | 8 (2) | 8 (2) | 0.274 | 8 (3) | 8 (2) | 0.304 |
| Global adherence | 4 (1) | 4 (0) | 0.185 | 4 (0) | 4 (0) | 0.200 |
| Adherence to shelter-in-place | 4 (2) | 4 (2) | 0.273 | 4 (3) | 4 (3) | 0.798 |
| Avoidance of social gatherings at home | 5 (1) | 4 (1) | 0.627 | 4 (1) | 4 (1) | 0.800 |
| Days per week out of home | 3 (6) | 2 (4) | 0.133 | 3 (5) | 2 (4) | 0.185 |
Abbreviations: IQR, interquartile range; SD, standard deviation; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; RT-PCR, real-time polymerase chain reaction; COVID-19, coronavirus disease 2019; DEFF, design effect; 95% CI, 95% confidence interval; NA, not applicable; BCG, bacillus Calmette-Guérin.
Following Brazilian Ministry of Health’s most current definition of active COVID-19.
Uncorrected for lateral flow immunoassay sensitivity.
Corrected for lateral flow immunoassay sensitivity of 76.24%.
US dollars corrected by OECD purchasing power parity.
One-to-five Likert scale: 1 = very poor adherence; 5 = very good adherence.
Zero-to-ten visual analogue scale: zero = no adherence; ten = perfect adherence.
Figure 2Forest plots of overall corrected prevalence of SARS-CoV-2 infection (A) and corrected prevalence difference between older and younger adults (B).
(A) Overall prevalence rates across surveys.
(B) Prevalence difference across surveys: older adults ≥60 years vs. adults 20–59 years.
Population size, estimated number of infections, infection prevalence, hospitalization, and fatality rates in the non-institutionalized general population.
| 20–39 years | 40–59 years | ≥60 years | |||||
|---|---|---|---|---|---|---|---|
| Estimate | 95% CI | Estimate | 95% CI | Estimate | 95% CI | R2; | |
| Population size, No | 29,857 | NA | 22,055 | NA | 9542 | NA | NA |
| Infections, No | 1245 | 875 to 1712 | 834 | 577 to 1164 | 216 | 128 to 341 | NA |
| Corrected prevalence, % | 4.17 | 2.93 to 5.73 | 3.78 | 2.62 to 5.28 | 2.26 | 1.34 to 3.58 | NA |
| Prevalence ratio | Refence | NA | 0.91 | 0.57 to 1.45 | 0.61 | 0.35 to 1.05 | NA |
| Hospitalization rate, % | 1.69 | 1.23 to 2.40 | 3.60 | 2.58 to 5.20 | 12.96 | 8.21 to 21.95 | 0.9783; |
| Number of infections per hospitalization, No | 59 | 42 to 81 | 28 | 19 to 39 | 8 | 5 to 12 | NA |
| Need for ICU, % | 0.64 | 0.47 to 0.91 | 1.2 | 0.86 to 1.73 | 5.09 | 3.22 to 8.62 | 0.9499; |
| Number of infections per ICU bed needed, No | 156 | 110 to 213 | 83 | 58 to 116 | 20 | 12 to 31 | NA |
| Need for IMV, % | 0.24 | 0.18 to 0.34 | 0.72 | 0.52 to 1.04 | 2.31 | 1.47 to 3.92 | 0.9996; |
| Number of infections per IMV needed, No | 417 | 294 to 556 | 139 | 96 to 192 | 43 | 26 to 68 | NA |
| Infection fatality rate, % | 0.08 | 0.06 to 0.11 | 0.24 | 0.17 to 0.35 | 4.63 | 2.93 to 7.84 | 0.9339; |
| Number of infections per death | 1250 | 909 to 1667 | 417 | 286 to 588 | 22 | 13 to 34 | NA |
R2P-values are all <0.0001; in equations, x is age group, wherein 20–39 y-o = 1, 40–49 y-o = 2, and ≥60 y-o = 3.
Rounded count to the closest integer.
Figure 3COVID-19 IFR, hospitalization rate, and need for ICU and IMV in the non-institutionalized general population.
Columns are rates. Red columns are infection fatality. Yellow columns are need for IMV. Blue columns are need for ICU. Green columns are hospitalization. Red, green, blue, and yellow doted lines are exponential trends for IFR, hospitalization, ICU, and IMV rates, respectively. Bars are 95% confidence intervals for rates.
Figure 4Forest plots of sex-, age-, income-, and schooling-adjusted prevalence ratios for infection.
(A) Adjusted prevalence ratios for meat-processing plant (MPP) workers v. non-MPP workers.
(B) Adjusted prevalence ratios for household contacts vs. general population.
(C) Unadjusted prevalence ratios for BCG vaccinated vs. non-vaccinated.